Posted by admin on Aug 13th, 2022

Envestnet Asset Management Inc. trimmed its holdings in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Rating) by 0.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 373,561 shares of the medical technology company’s stock after selling 1,227 shares during the quarter. Envestnet Asset Management Inc. owned about 0.37% of Alphatec worth $4,296,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the business. TownSquare Capital LLC increased its holdings in Alphatec by 3.1% in the 1st quarter. TownSquare Capital LLC now owns 53,827 shares of the medical technology company’s stock valued at $619,000 after buying an additional 1,609 shares during the period. BNP Paribas Arbitrage SA increased its holdings in Alphatec by 17.4% in the 4th quarter. BNP Paribas Arbitrage SA now owns 15,218 shares of the medical technology company’s stock valued at $174,000 after buying an additional 2,259 shares during the period. Cullen Frost Bankers Inc. increased its holdings in Alphatec by 4.5% in the 4th quarter. Cullen Frost Bankers Inc. now owns 55,365 shares of the medical technology company’s stock valued at $633,000 after buying an additional 2,385 shares during the period. Swiss National Bank increased its holdings in Alphatec by 2.3% in the 4th quarter. Swiss National Bank now owns 143,200 shares of the medical technology company’s stock valued at $1,637,000 after buying an additional 3,200 shares during the period. Finally, Perkins Capital Management Inc. increased its holdings in Alphatec by 4.4% in the 1st quarter. Perkins Capital Management Inc. now owns 174,500 shares of the medical technology company’s stock valued at $2,007,000 after buying an additional 7,400 shares during the period. 53.52% of the stock is owned by institutional investors.

Several equities analysts have commented on ATEC shares. Lake Street Capital reissued a “buy” rating and issued a $9.00 target price on shares of Alphatec in a report on Friday, July 15th. The Goldman Sachs Group reduced their price target on shares of Alphatec from $11.00 to $9.50 and set a “neutral” rating on the stock in a research note on Monday, August 8th. HC Wainwright raised their price target on shares of Alphatec from $19.00 to $20.00 in a research note on Friday, May 6th. Finally, Needham & Company LLC reduced their price target on shares of Alphatec from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Thursday, May 26th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $15.08.

NASDAQ:ATEC opened at $9.62 on Friday. The firm’s 50 day simple moving average is $7.22 and its 200 day simple moving average is $9.27. The company has a debt-to-equity ratio of 29.74, a current ratio of 2.19 and a quick ratio of 1.76. Alphatec Holdings, Inc. has a one year low of $5.73 and a one year high of $15.31. The company has a market cap of $1.01 billion, a PE ratio of -5.94 and a beta of 1.62.

In other Alphatec news, major shareholder Paul Segal bought 50,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 14th. The shares were acquired at an average cost of $6.95 per share, for a total transaction of $347,500.00. Following the transaction, the insider now directly owns 288,825 shares in the company, valued at $2,007,333.75. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, major shareholder Paul Segal purchased 50,000 shares of the company’s stock in a transaction dated Tuesday, June 14th. The shares were purchased at an average price of $6.95 per share, for a total transaction of $347,500.00. Following the transaction, the insider now owns 288,825 shares of the company’s stock, valued at $2,007,333.75. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director James L. L Tullis purchased 7,500 shares of the company’s stock in a transaction dated Wednesday, June 15th. The stock was purchased at an average price of $6.76 per share, for a total transaction of $50,700.00. Following the transaction, the director now directly owns 187,558 shares in the company, valued at approximately $1,267,892.08. The disclosure for this purchase can be found here. In the last ninety days, insiders have acquired 77,700 shares of company stock worth $547,400 and have sold 300,000 shares worth $2,339,500. 33.93% of the stock is owned by corporate insiders.

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement.

Want to see what other hedge funds are holding ATEC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Rating).

Receive News & Ratings for Alphatec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec and related companies with MarketBeat.com's FREE daily email newsletter.

BeiGene, Ltd. (NASDAQ:BGNE) Position Increased by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. Purchases 20,102 Shares of HealthEquity, Inc. (NASDAQ:HQY)